Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
IOCT: Innovator's International Developed Power Buffer ETF

IOCT: Innovator's International Developed Power Buffer ETF

Key Takeaways

  • IOCT is an actively managed, defined-outcome exchange-traded fund (ETF) from Innovator Capital Management that provides exposure to international developed-market equities.
  • The fund seeks to track the return of the iShares MSCI EAFE ETF (EFA) up to a cap, while buffering investors against the first 15% of losses over a one-year outcome period.
  • IOCT uses Flexible Exchange (FLEX) Options referencing EFA, rather than buying the underlying stocks directly, and is classified as non-diversified.
  • The fund carries a net expense ratio of 0.85% and resets its buffer and cap approximately annually each October.
  • The ETF is designed for investors seeking international developed-market exposure with built-in downside protection in exchange for capped upside.

Getting Started with IOCT

The Innovator International Developed Power Buffer ETF – October, traded under the ticker IOCT, is a specialized exchange-traded fund (ETF) — a pooled investment vehicle that trades on an exchange like a stock. Launched by Innovator Capital Management and listed on NYSE Arca, it belongs to Innovator's "Defined Outcome" family of buffer ETFs. These funds are engineered to deliver a specific range of outcomes over a set period, offering investors a measure of downside protection in exchange for limiting upside gains.

The Investment Strategy Behind IOCT

IOCT's investment objective is straightforward but distinctive. The fund seeks to track the return of the iShares MSCI EAFE ETF (EFA), a widely followed benchmark vehicle for large- and mid-cap stocks across developed markets outside the U.S. and Canada — primarily Europe, Australasia, and the Far East. Rather than owning EFA or its underlying equities outright, IOCT invests at least 80% of its net assets in Flexible Exchange Options, or FLEX Options, that reference EFA. FLEX Options are customizable exchange-traded options contracts whose settlement is guaranteed by the Options Clearing Corporation (OCC). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

This structure creates a "defined outcome" over an approximately one-year period, which resets each October. Over that outcome period, IOCT aims to buffer investors against the first 15% of EFA losses while capping upside participation at a predetermined level. Importantly, the buffer and cap apply only if an investor holds shares from the first day of the outcome period through the last day; investors who buy or sell mid-period will experience different results.

IOCT is actively managed and non-diversified, meaning it is not bound to spread its holdings across many securities in the way diversified funds are. Its portfolio is concentrated, typically holding a small number of FLEX Options positions plus cash or collateral, rather than hundreds of individual stocks.

Holdings and Sector Exposure

Because IOCT achieves its exposure through options rather than direct stock ownership, its holdings list is short — generally just a handful of FLEX Option positions on EFA. The underlying economic exposure, however, reflects the broad sector mix of the MSCI EAFE Index. That sector allocation has historically been led by financial services and industrials, followed by healthcare, technology, consumer cyclical, and consumer defensive names, with smaller allocations to basic materials, communication services, utilities, energy, and real estate.

This gives IOCT a diversified international developed-market footprint through a single, defined-outcome wrapper. The fund's expense ratio is 0.85%, which is higher than a conventional broad-market international index ETF but reflects the cost of the options-based buffer and cap structure.

Why Investors Follow IOCT

IOCT attracts attention primarily from investors who want international developed-market exposure but are concerned about downside volatility. Its defining feature is the 15% buffer, which cushions the first portion of losses over each outcome period. This can make it appealing for risk-conscious investors, those nearing a specific financial goal, or those seeking to diversify beyond U.S. equities without taking on the full drawdown risk of an unhedged international position.

The trade-off is the upside cap. In exchange for that downside buffer, IOCT limits how much of EFA's gains investors can capture in any given outcome period. The fund's annual reset also means the buffer and cap levels are re-established each October, giving the ETF a recurring, evergreen structure that can be held indefinitely across multiple outcome periods.

Key Risks and Considerations

Investors should weigh several factors before considering IOCT. The capped upside means the fund may underperform an unhedged international index during strong market rallies. Conversely, the 15% buffer does not eliminate risk — losses beyond that threshold are still borne by the investor, and the buffer only applies if shares are held for the full outcome period.

The fund is also non-diversified and relies on FLEX Options, which can be less liquid than standard exchange-traded options and carry counterparty risk tied to the Options Clearing Corporation. International developed-market equities remain subject to currency fluctuations, geopolitical developments, and regional economic cycles. Finally, the 0.85% expense ratio is meaningfully higher than many plain-vanilla international index ETFs, which can erode returns over time.

Conclusion

The Innovator International Developed Power Buffer ETF – October (IOCT) occupies a specialized niche in the ETF landscape. By pairing international developed-market exposure with a 15% downside buffer and a capped upside, it offers a distinctive risk-management profile that plain index funds do not provide. For investors who want overseas diversification with built-in protection — and who accept the trade-off of limited gains — IOCT remains a relevant and recurring option in Innovator's defined-outcome lineup.

Using Tickeron AI Tools for Research

In my own analysis process, I often rely on Tickeron's AI Screener to evaluate ETFs like IOCT alongside peers. It helps surface ideas based on technical indicators, fundamentals, and customizable filters, which can be useful when screening for defined-outcome strategies that align with a particular risk profile.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IOCT

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


IOCT in downward trend: price dove below 50-day moving average on November 16, 2026

IOCT moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 18 of 28 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IOCT as a result. In 48 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for IOCT turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 31 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IOCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

IOCT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +0.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where IOCT advanced for three days, in 235 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Industry description

The investment seeks to provide investors with returns that match the price return of the iShares MSCI EAFE ETF. The fund invests at least 80% of its net assets in FLexible EXchange® Options (“FLEX Options”) that reference the iShares MSCI EAFE ETF. FLEX Options are exchange-traded options contracts with uniquely customizable terms. Although guaranteed for settlement by the Options Clearing Corporation (the “OCC”), FLEX Options are still subject to counterparty risk with the OCC and may be less liquid than more traditional exchange-traded options. The fund is non-diversified.
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.